The Markets Are Not Strongly Efficient
Streetwise for Friday, May 11, 2018 “Get your facts first, then you can distort them as you please.” – Mark Twain A year ago, I discussed a paper written by...
Category
Streetwise
Apple Knocks the Cover Off the Ball
Streetwise for Sunday, May 6, 2018 Given the many facets of uncertainty facing the financial markets, does Wall Street still make sense? Absolutely! The opportunities to...
Think of Investing as an Athletic Competition
Streetwise for Friday, May 4, 2018 Investing should not be about turning you into a candidate for Prozac. When the market hiccups simply take it in stride. Certainly, the...
Rudd’s MarketView Stock Column Wednesday, May 2, 2018
The major domestic equity indexes were lower on Wednesday as potential restrictions by the United States on Chinese telecom companies reinforced the Street’s concerns...
Rudd’s MarketView Stock Column Monday, April 23, 2018
Wall Street ended the trading day on Monday with little change as concerns about soft smartphone demand weighed on tech stocks and pulled the Nasdaq lower while earnings...
A Take on Tesla (TSLA)
Streetwise for Sunday, April 22, 2018 While investment opportunities are always plentiful, you need to have a willingness to belly up to the bar and take decisive action with...
Wall Street versus Las Vegas – It’s the Odds
Streetwise for Friday, April 20, 2018 Let me state at the onset that I dislike analogies comparing Wall Street to Las Vegas. Investing and gambling are not the same. Yet, I...
Those Desiring to Perpetrate Fraud Are Endlessly Creative
Streetwise for Sunday, April 15, 2018 Facebook CEO Mark Zuckerberg appeared before the House Commerce Committee on April 11, to explain his company’s part in the...
Balance Fears and Expectations
Streetwise for Friday, April 13, 2018 One of the most difficult challenges in today’s investment climate is maintaining a reality check on your expectations. Given the...
A Discussion of AbbVie (ABBV)
Streetwise for Sunday, April 8, 2018 If you are short on investment ideas, one company you might want to consider as a research candidate is AbbVie (ABBV), this despite its...